BioSig Technologies, Inc. (NASDAQ: BSGM) Stock Competitors & Peer Comparison
See BSGM's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for BSGM and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BSGM | $6.10 | +37.08% | 191.1M | -5.81 | -$1.05 | N/A |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| ABT | $97.24 | -1.60% | 167.3B | 18.56 | $5.21 | +2.54% |
| MDT | $86.32 | +0.03% | 110.7B | 15.63 | $5.53 | +3.30% |
| SYK | $275.61 | +0.08% | 104.7B | 20.39 | $13.39 | +1.28% |
| BSX | $43.04 | -1.41% | 64.3B | 13.95 | $3.10 | N/A |
| EW | $85.47 | -0.99% | 49.1B | 31.56 | $2.70 | N/A |
| DXCM | $84.97 | -1.53% | 32.5B | 33.82 | $2.55 | N/A |
| GEHC | $64.14 | -1.88% | 28.9B | 14.03 | $4.56 | +0.22% |
| PHG | $23.86 | -2.35% | 23.3B | 13.60 | $1.75 | +4.17% |
Stock Comparison
Boston Scientific Corporation (NYSE: BSX-PA)
BSGM vs BSX-PA Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, BSGM's ROE is +15.26%, compared to BSX-PA's ROE of +0.15%. Regarding short-term risk, BSGM is more volatile compared to BSX-PA. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check BSX-PA's competition here
Abbott Laboratories (NYSE: ABT)
BSGM vs ABT Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, ABT has a market cap of 167.3B. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while ABT trades at $97.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas ABT's P/E ratio is 18.56. In terms of profitability, BSGM's ROE is +15.26%, compared to ABT's ROE of +0.11%. Regarding short-term risk, BSGM is more volatile compared to ABT. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check ABT's competition here
Medtronic plc (NYSE: MDT)
BSGM vs MDT Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, MDT has a market cap of 110.7B. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while MDT trades at $86.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas MDT's P/E ratio is 15.63. In terms of profitability, BSGM's ROE is +15.26%, compared to MDT's ROE of +0.11%. Regarding short-term risk, BSGM is more volatile compared to MDT. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check MDT's competition here
Stryker Corporation (NYSE: SYK)
BSGM vs SYK Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, SYK has a market cap of 104.7B. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while SYK trades at $275.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas SYK's P/E ratio is 20.39. In terms of profitability, BSGM's ROE is +15.26%, compared to SYK's ROE of +0.16%. Regarding short-term risk, BSGM is more volatile compared to SYK. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check SYK's competition here
Boston Scientific Corporation (NYSE: BSX)
BSGM vs BSX Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, BSX has a market cap of 64.3B. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while BSX trades at $43.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas BSX's P/E ratio is 13.95. In terms of profitability, BSGM's ROE is +15.26%, compared to BSX's ROE of +0.15%. Regarding short-term risk, BSGM is more volatile compared to BSX. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check BSX's competition here
Edwards Lifesciences Corporation (NYSE: EW)
BSGM vs EW Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, EW has a market cap of 49.1B. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while EW trades at $85.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas EW's P/E ratio is 31.56. In terms of profitability, BSGM's ROE is +15.26%, compared to EW's ROE of +0.10%. Regarding short-term risk, BSGM is more volatile compared to EW. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check EW's competition here
DexCom, Inc. (NASDAQ: DXCM)
BSGM vs DXCM Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, DXCM has a market cap of 32.5B. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while DXCM trades at $84.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas DXCM's P/E ratio is 33.82. In terms of profitability, BSGM's ROE is +15.26%, compared to DXCM's ROE of +0.36%. Regarding short-term risk, BSGM is more volatile compared to DXCM. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check DXCM's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
BSGM vs GEHC Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, GEHC has a market cap of 28.9B. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while GEHC trades at $64.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas GEHC's P/E ratio is 14.03. In terms of profitability, BSGM's ROE is +15.26%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, BSGM is more volatile compared to GEHC. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check GEHC's competition here
Koninklijke Philips N.V. (NYSE: PHG)
BSGM vs PHG Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, PHG has a market cap of 23.3B. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while PHG trades at $23.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas PHG's P/E ratio is 13.60. In terms of profitability, BSGM's ROE is +15.26%, compared to PHG's ROE of +0.10%. Regarding short-term risk, BSGM is more volatile compared to PHG. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check PHG's competition here
Abiomed, Inc. (NASDAQ: ABMD)
BSGM vs ABMD Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas ABMD's P/E ratio is 65.36. In terms of profitability, BSGM's ROE is +15.26%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, BSGM is more volatile compared to ABMD. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check ABMD's competition here
Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
BSGM vs ZBH Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, ZBH has a market cap of 17B. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while ZBH trades at $87.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas ZBH's P/E ratio is 10.38. In terms of profitability, BSGM's ROE is +15.26%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, BSGM is more volatile compared to ZBH. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check ZBH's competition here
ShockWave Medical, Inc. (NASDAQ: SWAV)
BSGM vs SWAV Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas SWAV's P/E ratio is 78.76. In terms of profitability, BSGM's ROE is +15.26%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, BSGM is more volatile compared to SWAV. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check SWAV's competition here
Penumbra, Inc. (NYSE: PEN)
BSGM vs PEN Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, PEN has a market cap of 12.5B. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while PEN trades at $318.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas PEN's P/E ratio is 83.04. In terms of profitability, BSGM's ROE is +15.26%, compared to PEN's ROE of +0.11%. Regarding short-term risk, BSGM is more volatile compared to PEN. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check PEN's competition here
Smith & Nephew plc (NYSE: SNN)
BSGM vs SNN Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, SNN has a market cap of 11.2B. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while SNN trades at $26.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas SNN's P/E ratio is 17.94. In terms of profitability, BSGM's ROE is +15.26%, compared to SNN's ROE of +0.12%. Regarding short-term risk, BSGM is more volatile compared to SNN. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check SNN's competition here
Align Technology, Inc. (NASDAQ: ALGN)
BSGM vs ALGN Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, ALGN has a market cap of 10.4B. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while ALGN trades at $144.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas ALGN's P/E ratio is 13.25. In terms of profitability, BSGM's ROE is +15.26%, compared to ALGN's ROE of +0.10%. Regarding short-term risk, BSGM is more volatile compared to ALGN. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check ALGN's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO-B)
BSGM vs BIO-B Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, BIO-B has a market cap of 10.3B. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while BIO-B trades at $368.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas BIO-B's P/E ratio is -66.26. In terms of profitability, BSGM's ROE is +15.26%, compared to BIO-B's ROE of +0.03%. Regarding short-term risk, BSGM is more volatile compared to BIO-B. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check BIO-B's competition here
Globus Medical, Inc. (NYSE: GMED)
BSGM vs GMED Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, GMED has a market cap of 10.1B. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while GMED trades at $75.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas GMED's P/E ratio is 16.87. In terms of profitability, BSGM's ROE is +15.26%, compared to GMED's ROE of +0.12%. Regarding short-term risk, BSGM is more volatile compared to GMED. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check GMED's competition here
Glaukos Corporation (NYSE: GKOS)
BSGM vs GKOS Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, GKOS has a market cap of 9.7B. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while GKOS trades at $164.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas GKOS's P/E ratio is -191.02. In terms of profitability, BSGM's ROE is +15.26%, compared to GKOS's ROE of -0.27%. Regarding short-term risk, BSGM is more volatile compared to GKOS. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check GKOS's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO)
BSGM vs BIO Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, BIO has a market cap of 9.6B. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while BIO trades at $365.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas BIO's P/E ratio is 38.31. In terms of profitability, BSGM's ROE is +15.26%, compared to BIO's ROE of +0.03%. Regarding short-term risk, BSGM is more volatile compared to BIO. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check BIO's competition here
Bruker Corporation (NASDAQ: BRKR)
BSGM vs BRKR Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, BRKR has a market cap of 9.4B. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while BRKR trades at $63.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas BRKR's P/E ratio is 31.13. In terms of profitability, BSGM's ROE is +15.26%, compared to BRKR's ROE of -0.03%. Regarding short-term risk, BSGM is more volatile compared to BRKR. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check BRKR's competition here
Masimo Corporation (NASDAQ: MASI)
BSGM vs MASI Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas MASI's P/E ratio is 44.43. In terms of profitability, BSGM's ROE is +15.26%, compared to MASI's ROE of +0.09%. Regarding short-term risk, BSGM is more volatile compared to MASI. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check MASI's competition here
Bruker Corporation (NASDAQ: BRKRP)
BSGM vs BRKRP Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, BRKRP has a market cap of 9.1B. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while BRKRP trades at $463.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas BRKRP's P/E ratio is 247.38. In terms of profitability, BSGM's ROE is +15.26%, compared to BRKRP's ROE of -0.03%. Regarding short-term risk, BSGM is more volatile compared to BRKRP. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check BRKRP's competition here
Insulet Corp. (NASDAQ: PODD)
BSGM vs PODD Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, PODD has a market cap of 9.1B. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while PODD trades at $131.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas PODD's P/E ratio is 22.29. In terms of profitability, BSGM's ROE is +15.26%, compared to PODD's ROE of +0.27%. Regarding short-term risk, BSGM is more volatile compared to PODD. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check PODD's competition here
Haemonetics Corporation (NYSE: HAE)
BSGM vs HAE Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, HAE has a market cap of 4.7B. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while HAE trades at $104.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas HAE's P/E ratio is 20.85. In terms of profitability, BSGM's ROE is +15.26%, compared to HAE's ROE of +0.11%. Regarding short-term risk, BSGM is more volatile compared to HAE. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check HAE's competition here
Inari Medical, Inc. (NASDAQ: NARI)
BSGM vs NARI Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas NARI's P/E ratio is -59.24. In terms of profitability, BSGM's ROE is +15.26%, compared to NARI's ROE of -0.00%. Regarding short-term risk, BSGM is more volatile compared to NARI. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check NARI's competition here
Integer Holdings Corporation (NYSE: ITGR)
BSGM vs ITGR Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, ITGR has a market cap of 4.3B. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while ITGR trades at $126.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas ITGR's P/E ratio is 19.91. In terms of profitability, BSGM's ROE is +15.26%, compared to ITGR's ROE of +0.07%. Regarding short-term risk, BSGM is more volatile compared to ITGR. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check ITGR's competition here
LivaNova PLC (NASDAQ: LIVN)
BSGM vs LIVN Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, LIVN has a market cap of 4.1B. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while LIVN trades at $75.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas LIVN's P/E ratio is 17.74. In terms of profitability, BSGM's ROE is +15.26%, compared to LIVN's ROE of +0.15%. Regarding short-term risk, BSGM is more volatile compared to LIVN. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check LIVN's competition here
iRhythm Technologies, Inc. (NASDAQ: IRTC)
BSGM vs IRTC Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, IRTC has a market cap of 3.6B. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while IRTC trades at $110.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas IRTC's P/E ratio is -258.26. In terms of profitability, BSGM's ROE is +15.26%, compared to IRTC's ROE of -0.09%. Regarding short-term risk, BSGM is more volatile compared to IRTC. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check IRTC's competition here
Axonics, Inc. (NASDAQ: AXNX)
BSGM vs AXNX Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas AXNX's P/E ratio is -709.80. In terms of profitability, BSGM's ROE is +15.26%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, BSGM is more volatile compared to AXNX. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check AXNX's competition here
TransMedics Group, Inc. (NASDAQ: TMDX)
BSGM vs TMDX Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, TMDX has a market cap of 2.7B. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while TMDX trades at $78.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas TMDX's P/E ratio is 39.92. In terms of profitability, BSGM's ROE is +15.26%, compared to TMDX's ROE of +0.33%. Regarding short-term risk, BSGM is more volatile compared to TMDX. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check TMDX's competition here
Neogen Corporation (NASDAQ: NEOG)
BSGM vs NEOG Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, NEOG has a market cap of 2.7B. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while NEOG trades at $12.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas NEOG's P/E ratio is 43.71. In terms of profitability, BSGM's ROE is +15.26%, compared to NEOG's ROE of -0.00%. Regarding short-term risk, BSGM is more volatile compared to NEOG. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check NEOG's competition here
UFP Technologies, Inc. (NASDAQ: UFPT)
BSGM vs UFPT Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, UFPT has a market cap of 2.3B. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while UFPT trades at $301.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas UFPT's P/E ratio is 30.13. In terms of profitability, BSGM's ROE is +15.26%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, BSGM is more volatile compared to UFPT. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check UFPT's competition here
Butterfly Network, Inc. (NYSE: BFLY)
BSGM vs BFLY Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, BFLY has a market cap of 2.3B. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while BFLY trades at $8.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas BFLY's P/E ratio is -35.52. In terms of profitability, BSGM's ROE is +15.26%, compared to BFLY's ROE of -0.38%. Regarding short-term risk, BSGM is more volatile compared to BFLY. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check BFLY's competition here
AxoGen, Inc. (NASDAQ: AXGN)
BSGM vs AXGN Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, AXGN has a market cap of 2.1B. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while AXGN trades at $37.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas AXGN's P/E ratio is 105.05. In terms of profitability, BSGM's ROE is +15.26%, compared to AXGN's ROE of -0.18%. Regarding short-term risk, BSGM is more volatile compared to AXGN. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check AXGN's competition here
NuVasive, Inc. (NASDAQ: NUVA)
BSGM vs NUVA Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas NUVA's P/E ratio is 75.00. In terms of profitability, BSGM's ROE is +15.26%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, BSGM is more volatile compared to NUVA. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check NUVA's competition here
Inspire Medical Systems, Inc. (NYSE: INSP)
BSGM vs INSP Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, INSP has a market cap of 2B. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while INSP trades at $70.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas INSP's P/E ratio is 31.19. In terms of profitability, BSGM's ROE is +15.26%, compared to INSP's ROE of +0.18%. Regarding short-term risk, BSGM is more volatile compared to INSP. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check INSP's competition here
Establishment Labs Holdings Inc. (NASDAQ: ESTA)
BSGM vs ESTA Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, ESTA has a market cap of 1.9B. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while ESTA trades at $63.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas ESTA's P/E ratio is -50.03. In terms of profitability, BSGM's ROE is +15.26%, compared to ESTA's ROE of -2.04%. Regarding short-term risk, BSGM is more volatile compared to ESTA. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check ESTA's competition here
Novocure Ltd (NASDAQ: NVCR)
BSGM vs NVCR Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, NVCR has a market cap of 1.9B. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while NVCR trades at $15.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas NVCR's P/E ratio is -12.25. In terms of profitability, BSGM's ROE is +15.26%, compared to NVCR's ROE of -0.44%. Regarding short-term risk, BSGM is more volatile compared to NVCR. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check NVCR's competition here
Alphatec Holdings, Inc. (NASDAQ: ATEC)
BSGM vs ATEC Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, ATEC has a market cap of 1.5B. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while ATEC trades at $9.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas ATEC's P/E ratio is -165.00. In terms of profitability, BSGM's ROE is +15.26%, compared to ATEC's ROE of -8.19%. Regarding short-term risk, BSGM is more volatile compared to ATEC. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check ATEC's competition here
CONMED Corporation (NYSE: CNMD)
BSGM vs CNMD Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, CNMD has a market cap of 1.4B. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while CNMD trades at $46.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas CNMD's P/E ratio is 10.09. In terms of profitability, BSGM's ROE is +15.26%, compared to CNMD's ROE of +0.06%. Regarding short-term risk, BSGM is more volatile compared to CNMD. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check CNMD's competition here
Heska Corporation (NASDAQ: HSKA)
BSGM vs HSKA Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas HSKA's P/E ratio is -62.49. In terms of profitability, BSGM's ROE is +15.26%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, BSGM is more volatile compared to HSKA. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check HSKA's competition here
Integra LifeSciences Holdings Corporation (NASDAQ: IART)
BSGM vs IART Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, IART has a market cap of 1.3B. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while IART trades at $12.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas IART's P/E ratio is 6.82. In terms of profitability, BSGM's ROE is +15.26%, compared to IART's ROE of -0.01%. Regarding short-term risk, BSGM is more volatile compared to IART. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check IART's competition here
Avanos Medical, Inc. (NYSE: AVNS)
BSGM vs AVNS Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while AVNS trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas AVNS's P/E ratio is 27.77. In terms of profitability, BSGM's ROE is +15.26%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, BSGM is more volatile compared to AVNS. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check AVNS's competition here
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
BSGM vs TNDM Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, TNDM has a market cap of 1.1B. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while TNDM trades at $16.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas TNDM's P/E ratio is -17.74. In terms of profitability, BSGM's ROE is +15.26%, compared to TNDM's ROE of -0.46%. Regarding short-term risk, BSGM is more volatile compared to TNDM. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check TNDM's competition here
Silk Road Medical, Inc (NASDAQ: SILK)
BSGM vs SILK Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas SILK's P/E ratio is -18.96. In terms of profitability, BSGM's ROE is +15.26%, compared to SILK's ROE of -0.35%. Regarding short-term risk, BSGM is more volatile compared to SILK. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check SILK's competition here
Paragon 28, Inc. (NYSE: FNA)
BSGM vs FNA Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas FNA's P/E ratio is -19.83. In terms of profitability, BSGM's ROE is +15.26%, compared to FNA's ROE of -0.35%. Regarding short-term risk, BSGM is more volatile compared to FNA. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check FNA's competition here
IRadimed Corporation (NASDAQ: IRMD)
BSGM vs IRMD Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, IRMD has a market cap of 1.1B. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while IRMD trades at $85.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas IRMD's P/E ratio is 42.86. In terms of profitability, BSGM's ROE is +15.26%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, BSGM is more volatile compared to IRMD. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check IRMD's competition here
Artivion, Inc. (NYSE: AORT)
BSGM vs AORT Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, AORT has a market cap of 1.1B. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while AORT trades at $22.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas AORT's P/E ratio is 36.55. In terms of profitability, BSGM's ROE is +15.26%, compared to AORT's ROE of -0.01%. Regarding short-term risk, BSGM is more volatile compared to AORT. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check AORT's competition here
Enovis Corporation (NYSE: ENOV)
BSGM vs ENOV Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, ENOV has a market cap of 1B. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while ENOV trades at $18.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas ENOV's P/E ratio is 5.18. In terms of profitability, BSGM's ROE is +15.26%, compared to ENOV's ROE of -0.68%. Regarding short-term risk, BSGM is more volatile compared to ENOV. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check ENOV's competition here
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI)
BSGM vs LMRI Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, LMRI has a market cap of 970.4M. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while LMRI trades at $10.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas LMRI's P/E ratio is -19.65. In terms of profitability, BSGM's ROE is +15.26%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, BSGM is more volatile compared to LMRI. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check LMRI's competition here
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
BSGM vs PRCT Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, PRCT has a market cap of 968.8M. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while PRCT trades at $17.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas PRCT's P/E ratio is -8.77. In terms of profitability, BSGM's ROE is +15.26%, compared to PRCT's ROE of -0.31%. Regarding short-term risk, BSGM is more volatile compared to PRCT. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check PRCT's competition here
Bioventus Inc. (NASDAQ: BVS)
BSGM vs BVS Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, BVS has a market cap of 911.2M. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while BVS trades at $13.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas BVS's P/E ratio is 17.70. In terms of profitability, BSGM's ROE is +15.26%, compared to BVS's ROE of +0.28%. Regarding short-term risk, BSGM is more volatile compared to BVS. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check BVS's competition here
CeriBell, Inc. (NASDAQ: CBLL)
BSGM vs CBLL Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, CBLL has a market cap of 895.8M. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while CBLL trades at $23.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas CBLL's P/E ratio is -13.41. In terms of profitability, BSGM's ROE is +15.26%, compared to CBLL's ROE of -0.45%. Regarding short-term risk, BSGM is more volatile compared to CBLL. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check CBLL's competition here
Beta Bionics, Inc. (NASDAQ: BBNX)
BSGM vs BBNX Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, BBNX has a market cap of 849M. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while BBNX trades at $18.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas BBNX's P/E ratio is -11.44. In terms of profitability, BSGM's ROE is +15.26%, compared to BBNX's ROE of -0.26%. Regarding short-term risk, BSGM is more volatile compared to BBNX. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check BBNX's competition here
Cardiovascular Systems, Inc. (NASDAQ: CSII)
BSGM vs CSII Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, CSII has a market cap of 844M. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas CSII's P/E ratio is -20.83. In terms of profitability, BSGM's ROE is +15.26%, compared to CSII's ROE of -0.14%. Regarding short-term risk, BSGM is more volatile compared to CSII. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check CSII's competition here
SI-BONE, Inc. (NASDAQ: SIBN)
BSGM vs SIBN Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, SIBN has a market cap of 816.5M. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while SIBN trades at $18.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas SIBN's P/E ratio is -54.15. In terms of profitability, BSGM's ROE is +15.26%, compared to SIBN's ROE of -0.08%. Regarding short-term risk, BSGM is more volatile compared to SIBN. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check SIBN's competition here
InMode Ltd. (NASDAQ: INMD)
BSGM vs INMD Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, INMD has a market cap of 807.6M. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while INMD trades at $14.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas INMD's P/E ratio is 9.76. In terms of profitability, BSGM's ROE is +15.26%, compared to INMD's ROE of +0.12%. Regarding short-term risk, BSGM is more volatile compared to INMD. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check INMD's competition here
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
BSGM vs PACB Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, PACB has a market cap of 779.6M. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while PACB trades at $2.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas PACB's P/E ratio is -6.12. In terms of profitability, BSGM's ROE is +15.26%, compared to PACB's ROE of -49.62%. Regarding short-term risk, BSGM is more volatile compared to PACB. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check PACB's competition here
Varex Imaging Corporation (NASDAQ: VREX)
BSGM vs VREX Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, VREX has a market cap of 778.4M. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while VREX trades at $18.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas VREX's P/E ratio is 19.46. In terms of profitability, BSGM's ROE is +15.26%, compared to VREX's ROE of +0.05%. Regarding short-term risk, BSGM is more volatile compared to VREX. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check VREX's competition here
AdaptHealth Corp. (NASDAQ: AHCO)
BSGM vs AHCO Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, AHCO has a market cap of 772.8M. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while AHCO trades at $5.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas AHCO's P/E ratio is 11.59. In terms of profitability, BSGM's ROE is +15.26%, compared to AHCO's ROE of -0.15%. Regarding short-term risk, BSGM is more volatile compared to AHCO. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check AHCO's competition here
Cytek Biosciences, Inc. (NASDAQ: CTKB)
BSGM vs CTKB Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, CTKB has a market cap of 750.3M. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while CTKB trades at $5.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas CTKB's P/E ratio is -30.78. In terms of profitability, BSGM's ROE is +15.26%, compared to CTKB's ROE of -0.24%. Regarding short-term risk, BSGM is more volatile compared to CTKB. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check CTKB's competition here
Anteris Technologies Global Corp. (NASDAQ: AVR)
BSGM vs AVR Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, AVR has a market cap of 739.9M. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while AVR trades at $7.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas AVR's P/E ratio is -3.92. In terms of profitability, BSGM's ROE is +15.26%, compared to AVR's ROE of -0.78%. Regarding short-term risk, BSGM is more volatile compared to AVR. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check AVR's competition here
Surmodics, Inc. (NASDAQ: SRDX)
BSGM vs SRDX Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas SRDX's P/E ratio is -34.66. In terms of profitability, BSGM's ROE is +15.26%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, BSGM is more volatile compared to SRDX. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check SRDX's competition here
Apollo Endosurgery, Inc. (NASDAQ: APEN)
BSGM vs APEN Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas APEN's P/E ratio is -9.43. In terms of profitability, BSGM's ROE is +15.26%, compared to APEN's ROE of -0.85%. Regarding short-term risk, BSGM is more volatile compared to APEN. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check APEN's competition here
OrthoPediatrics Corp. (NASDAQ: KIDS)
BSGM vs KIDS Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, KIDS has a market cap of 557.1M. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while KIDS trades at $22.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas KIDS's P/E ratio is -18.38. In terms of profitability, BSGM's ROE is +15.26%, compared to KIDS's ROE of -0.12%. Regarding short-term risk, BSGM is more volatile compared to KIDS. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check KIDS's competition here
SS Innovations International, Inc. (NASDAQ: SSII)
BSGM vs SSII Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, SSII has a market cap of 550.4M. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while SSII trades at $2.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas SSII's P/E ratio is -45.83. In terms of profitability, BSGM's ROE is +15.26%, compared to SSII's ROE of -0.27%. Regarding short-term risk, BSGM is more volatile compared to SSII. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check SSII's competition here
ZimVie Inc. (NASDAQ: ZIMV)
BSGM vs ZIMV Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, BSGM's ROE is +15.26%, compared to ZIMV's ROE of -0.07%. Regarding short-term risk, BSGM is more volatile compared to ZIMV. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check ZIMV's competition here
Delcath Systems, Inc. (NASDAQ: DCTH)
BSGM vs DCTH Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, DCTH has a market cap of 532M. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while DCTH trades at $15.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas DCTH's P/E ratio is 1541.00. In terms of profitability, BSGM's ROE is +15.26%, compared to DCTH's ROE of +0.00%. Regarding short-term risk, BSGM is more volatile compared to DCTH. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check DCTH's competition here
Sight Sciences, Inc. (NASDAQ: SGHT)
BSGM vs SGHT Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, SGHT has a market cap of 491.3M. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while SGHT trades at $8.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas SGHT's P/E ratio is -16.12. In terms of profitability, BSGM's ROE is +15.26%, compared to SGHT's ROE of -0.51%. Regarding short-term risk, BSGM is more volatile compared to SGHT. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check SGHT's competition here
Tactile Systems Technology, Inc. (NASDAQ: TCMD)
BSGM vs TCMD Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, TCMD has a market cap of 489.7M. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while TCMD trades at $22.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas TCMD's P/E ratio is 20.10. In terms of profitability, BSGM's ROE is +15.26%, compared to TCMD's ROE of +0.11%. Regarding short-term risk, BSGM is more volatile compared to TCMD. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check TCMD's competition here
Cerus Corporation (NASDAQ: CERS)
BSGM vs CERS Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, CERS has a market cap of 467.5M. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while CERS trades at $2.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas CERS's P/E ratio is -77.08. In terms of profitability, BSGM's ROE is +15.26%, compared to CERS's ROE of -0.10%. Regarding short-term risk, BSGM is more volatile compared to CERS. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check CERS's competition here
NeuroPace, Inc. (NASDAQ: NPCE)
BSGM vs NPCE Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, NPCE has a market cap of 448.3M. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while NPCE trades at $12.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas NPCE's P/E ratio is -23.07. In terms of profitability, BSGM's ROE is +15.26%, compared to NPCE's ROE of -1.20%. Regarding short-term risk, BSGM is more volatile compared to NPCE. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check NPCE's competition here
Senseonics Holdings, Inc. (NASDAQ: SENS)
BSGM vs SENS Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, SENS has a market cap of 416.3M. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while SENS trades at $9.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas SENS's P/E ratio is -4.47. In terms of profitability, BSGM's ROE is +15.26%, compared to SENS's ROE of -1.66%. Regarding short-term risk, BSGM is more volatile compared to SENS. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check SENS's competition here
Orthofix Medical Inc. (NASDAQ: OFIX)
BSGM vs OFIX Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, OFIX has a market cap of 372.3M. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while OFIX trades at $9.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas OFIX's P/E ratio is -6.00. In terms of profitability, BSGM's ROE is +15.26%, compared to OFIX's ROE of -0.14%. Regarding short-term risk, BSGM is more volatile compared to OFIX. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check OFIX's competition here
ClearPoint Neuro, Inc. (NASDAQ: CLPT)
BSGM vs CLPT Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, CLPT has a market cap of 343.4M. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while CLPT trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas CLPT's P/E ratio is -9.70. In terms of profitability, BSGM's ROE is +15.26%, compared to CLPT's ROE of -1.88%. Regarding short-term risk, BSGM is more volatile compared to CLPT. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check CLPT's competition here
CapsoVision, Inc. (NASDAQ: CV)
BSGM vs CV Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, CV has a market cap of 315.8M. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while CV trades at $6.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas CV's P/E ratio is -10.03. In terms of profitability, BSGM's ROE is +15.26%, compared to CV's ROE of -1.78%. Regarding short-term risk, BSGM is more volatile compared to CV. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check CV's competition here
Perspective Therapeutics, Inc. (AMEX: CATX)
BSGM vs CATX Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, CATX has a market cap of 311.3M. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while CATX trades at $2.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas CATX's P/E ratio is -2.05. In terms of profitability, BSGM's ROE is +15.26%, compared to CATX's ROE of -0.42%. Regarding short-term risk, BSGM is more volatile compared to CATX. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check CATX's competition here
Semler Scientific, Inc. (NASDAQ: SMLR)
BSGM vs SMLR Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas SMLR's P/E ratio is 3.92. In terms of profitability, BSGM's ROE is +15.26%, compared to SMLR's ROE of +0.06%. Regarding short-term risk, BSGM is more volatile compared to SMLR. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check SMLR's competition here
Avita Medical Inc. (NASDAQ: RCEL)
BSGM vs RCEL Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, RCEL has a market cap of 298.4M. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while RCEL trades at $12.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas RCEL's P/E ratio is -8.34. In terms of profitability, BSGM's ROE is +15.26%, compared to RCEL's ROE of +2.32%. Regarding short-term risk, BSGM is more volatile compared to RCEL. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check RCEL's competition here
Quantum-Si incorporated (NASDAQ: QSI)
BSGM vs QSI Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, QSI has a market cap of 282.9M. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while QSI trades at $1.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas QSI's P/E ratio is -3.11. In terms of profitability, BSGM's ROE is +15.26%, compared to QSI's ROE of -0.47%. Regarding short-term risk, BSGM is more volatile compared to QSI. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check QSI's competition here
Treace Medical Concepts, Inc. (NASDAQ: TMCI)
BSGM vs TMCI Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, TMCI has a market cap of 280.9M. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while TMCI trades at $4.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas TMCI's P/E ratio is -4.61. In terms of profitability, BSGM's ROE is +15.26%, compared to TMCI's ROE of -0.74%. Regarding short-term risk, BSGM is more volatile compared to TMCI. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check TMCI's competition here
InfuSystem Holdings, Inc. (AMEX: INFU)
BSGM vs INFU Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, INFU has a market cap of 258.5M. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while INFU trades at $12.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas INFU's P/E ratio is 31.24. In terms of profitability, BSGM's ROE is +15.26%, compared to INFU's ROE of +0.15%. Regarding short-term risk, BSGM is more volatile compared to INFU. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check INFU's competition here
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
BSGM vs TLSI Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, TLSI has a market cap of 255.5M. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while TLSI trades at $4.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas TLSI's P/E ratio is -2.47. In terms of profitability, BSGM's ROE is +15.26%, compared to TLSI's ROE of +2.74%. Regarding short-term risk, BSGM is more volatile compared to TLSI. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check TLSI's competition here
Monogram Orthopaedics, Inc. (NASDAQ: MGRM)
BSGM vs MGRM Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas MGRM's P/E ratio is -12.00. In terms of profitability, BSGM's ROE is +15.26%, compared to MGRM's ROE of -0.85%. Regarding short-term risk, BSGM is more volatile compared to MGRM. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check MGRM's competition here
Electromed, Inc. (AMEX: ELMD)
BSGM vs ELMD Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, ELMD has a market cap of 236M. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while ELMD trades at $27.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas ELMD's P/E ratio is 21.76. In terms of profitability, BSGM's ROE is +15.26%, compared to ELMD's ROE of +0.23%. Regarding short-term risk, BSGM is more volatile compared to ELMD. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check ELMD's competition here
Nevro Corp. (NYSE: NVRO)
BSGM vs NVRO Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas NVRO's P/E ratio is -1.91. In terms of profitability, BSGM's ROE is +15.26%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, BSGM is more volatile compared to NVRO. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check NVRO's competition here
Profound Medical Corp. (NASDAQ: PROF)
BSGM vs PROF Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, PROF has a market cap of 212.6M. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while PROF trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas PROF's P/E ratio is -5.97. In terms of profitability, BSGM's ROE is +15.26%, compared to PROF's ROE of -0.56%. Regarding short-term risk, BSGM is more volatile compared to PROF. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check PROF's competition here
RxSight, Inc. (NASDAQ: RXST)
BSGM vs RXST Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, RXST has a market cap of 196.6M. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while RXST trades at $4.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas RXST's P/E ratio is -4.20. In terms of profitability, BSGM's ROE is +15.26%, compared to RXST's ROE of -0.17%. Regarding short-term risk, BSGM is more volatile compared to RXST. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check RXST's competition here
Xylo Technologies Ltd. (NASDAQ: MDGS)
BSGM vs MDGS Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas MDGS's P/E ratio is -0.27. In terms of profitability, BSGM's ROE is +15.26%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, BSGM is more volatile compared to MDGS. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check MDGS's competition here
Quipt Home Medical Corp. (NASDAQ: QIPT)
BSGM vs QIPT Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas QIPT's P/E ratio is -15.87. In terms of profitability, BSGM's ROE is +15.26%, compared to QIPT's ROE of -0.10%. Regarding short-term risk, BSGM is more volatile compared to QIPT. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check QIPT's competition here
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL)
BSGM vs FOCL Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, FOCL has a market cap of 161.9M. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while FOCL trades at $4.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas FOCL's P/E ratio is -4.18. In terms of profitability, BSGM's ROE is +15.26%, compared to FOCL's ROE of -2.90%. Regarding short-term risk, BSGM is more volatile compared to FOCL. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check FOCL's competition here
Inogen, Inc. (NASDAQ: INGN)
BSGM vs INGN Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, INGN has a market cap of 161.9M. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while INGN trades at $5.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas INGN's P/E ratio is -6.57. In terms of profitability, BSGM's ROE is +15.26%, compared to INGN's ROE of -0.13%. Regarding short-term risk, BSGM is more volatile compared to INGN. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check INGN's competition here
Quanterix Corporation (NASDAQ: QTRX)
BSGM vs QTRX Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, QTRX has a market cap of 160.6M. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while QTRX trades at $3.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas QTRX's P/E ratio is -1.34. In terms of profitability, BSGM's ROE is +15.26%, compared to QTRX's ROE of -0.44%. Regarding short-term risk, BSGM is more volatile compared to QTRX. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check QTRX's competition here
Neuronetics, Inc. (NASDAQ: STIM)
BSGM vs STIM Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, STIM has a market cap of 154.5M. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while STIM trades at $2.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas STIM's P/E ratio is -5.05. In terms of profitability, BSGM's ROE is +15.26%, compared to STIM's ROE of -1.51%. Regarding short-term risk, BSGM is more volatile compared to STIM. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check STIM's competition here
Lucid Diagnostics Inc. (NASDAQ: LUCD)
BSGM vs LUCD Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, LUCD has a market cap of 121.1M. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while LUCD trades at $0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas LUCD's P/E ratio is -1.72. In terms of profitability, BSGM's ROE is +15.26%, compared to LUCD's ROE of -4.04%. Regarding short-term risk, BSGM is more volatile compared to LUCD. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check LUCD's competition here
iCAD, Inc. (NASDAQ: ICAD)
BSGM vs ICAD Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas ICAD's P/E ratio is -20.37. In terms of profitability, BSGM's ROE is +15.26%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, BSGM is more volatile compared to ICAD. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check ICAD's competition here
Hancock Jaffe Laboratories (NASDAQ: HJLI)
BSGM vs HJLI Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas HJLI's P/E ratio is N/A. In terms of profitability, BSGM's ROE is +15.26%, compared to HJLI's ROE of -0.62%. Regarding short-term risk, BSGM is more volatile compared to HJLI. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check HJLI's competition here
Asensus Surgical, Inc. (AMEX: ASXC)
BSGM vs ASXC Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, ASXC has a market cap of 94.9M. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while ASXC trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas ASXC's P/E ratio is -1.12. In terms of profitability, BSGM's ROE is +15.26%, compared to ASXC's ROE of -1.18%. Regarding short-term risk, BSGM is more volatile compared to ASXC. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check ASXC's competition here
electroCore, Inc. (NASDAQ: ECOR)
BSGM vs ECOR Comparison October 2026
BioSig Technologies, Inc. (NASDAQ: BSGM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 191.1M. In comparison, ECOR has a market cap of 93M. Regarding current trading prices, BSGM is priced at $6.10 on the NASDAQ, while ECOR trades at $10.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -5.81, whereas ECOR's P/E ratio is -6.14. In terms of profitability, BSGM's ROE is +15.26%, compared to ECOR's ROE of +5.25%. Regarding short-term risk, BSGM is more volatile compared to ECOR. This indicates higher risk in terms of short-term price fluctuations for BSGM.Check ECOR's competition here